Showing results (231-240 of 253) with videos related to
Sort By:
Pageof 26
Frontiers in Immunology|May 29, 2024
Protein kinase CK2α is overexpressed in classical hodgkin lymphoma, regulates key signaling pathways, PD-L1 and may represent a new target for therapyEdoardo Ruggeri, Federica Frezzato, Nayla Mouawad, et al.Oncotarget|October 6, 2017
STAT3 mutation impacts biological and clinical features of T-LGL leukemiaAntonella Teramo, Gregorio Barilà, Giulia Calabretto, et al.British Journal of Haematology|June 12, 2026
From variant detection to interpretation in idiopathic erythrocytosis: A structured approach applied to a clinical cohortAlessandra Giannella, Fabrizio Vianello, Simone Zoletto, et al.Haematologica|June 7, 2021
The complex karyotype landscape in chronic lymphocytic leukemia allows the refinement of the risk of Richter syndrome transformationAndrea Visentin, Laura Bonaldi, Gian Matteo Rigolin, et al.European Journal of Haematology|June 17, 2020
Primary pancreatic lymphoma: Clinical presentation, diagnosis, treatment, and outcomeDavide Facchinelli, Sokol Sina, Enrico Boninsegna, et al.American Journal of Hematology|April 10, 2026
A Real-Life Multicenter Study of Checkpoint Inhibitors in Relapsed/Refractory Primary Mediastinal B-Cell LymphomaGabriele Gugliotta, Lisa Argnani, Martina Cantelli, et al.Journal of Clinical Medicine|January 11, 2025
Predictors of Splenectomy Response in Immune Thrombocytopenia: A Multicentric Italian StudySimone Zoletto, Marco Pizzi, Andrea De Crescenzo, et al.American Journal of Hematology|August 12, 2020
Younger patients with Waldenström Macroglobulinemia exhibit low risk profile and excellent outcomes in the era of immunotherapy and targeted therapiesMarzia Varettoni, Angela Ferrari, Anna M Frustaci, et al.Hemasphere|November 29, 2023
CK2β Regulates Hematopoietic Stem Cell Biology and ErythropoiesisLaura Quotti Tubi, Sara Canovas Nunes, Elisa Mandato, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2022
Direct-Acting Antivirals as Primary Treatment for Hepatitis C Virus-Associated Indolent Non-Hodgkin Lymphomas: The BArT Study of the Fondazione Italiana LinfomiMichele Merli, Sara Rattotti, Michele Spina, et al.Pageof 26